Exact Sciences Stock Forecast, Price & News NASDAQ:EXAS

Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

These investments are speculative, involve substantial risks , and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

What is the 52-week high for EXAS stock?

The P/E ratio of Exact Sciences is -18.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. 6 people have added Exact Sciences to their MarketBeat watchlist in the last 30 days. Only 22 people have searched for EXAS on MarketBeat in the last 30 days. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.

Discuss news and analysts’ price predictions with the investor community. Intraday Data provided by FACTSET and subject to terms of use. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.

The consensus among Wall Street research analysts is that investors should “buy” EXAS shares. EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI. Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally.

What is Exact Sciences Corp’s stock style?

As a general rule, the price of a T-bills moves inversely to changes in interest rates. See Jiko U.S. Treasuries Risk Disclosures for further details. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends.

If you had invested in Exact Sciences stock at $15.00, your return over the last 22 years would have been 327.13%, for an annualized return of 6.82% . A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Following a frenzy of inflows, investors are fleeing for the exits amid the fund’s underperformance this year. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

The up/down can my credit score go up 100 points in a month is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability – yield is subject to change. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk.

Quotes & News

328 employees have rated https://1investing.in/ Chief Executive Officer Kevin T. Conroy on Glassdoor.com. Kevin T. Conroy has an approval rating of 97% among the company’s employees. This puts Kevin T. Conroy in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at Exact Sciences to a friend.

Measures how much net income or profit is generated as a percentage of revenue.

• “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of (“Regulation A”).
• ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
• Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser.
• Additional information about your broker can be found by clicking here.

Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

On average, they anticipate the company’s stock price to reach $73.31 in the next year. This suggests a possible upside of 14.4% from the stock’s current price. View analysts price targets for EXAS or view top-rated stocks among Wall Street analysts. 12 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Exact Sciences in the last twelve months. There are currently 4 hold ratings and 8 buy ratings for the stock.

Dividend Strength

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.

Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

You can find your newly purchased EXAS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, and alternative assets. An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Related Stocks

Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Real-time analyst ratings, insider transactions, earnings data, and more. Represents the company’s profit divided by the outstanding shares of its common stock. The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

U.S. Treasuries (“T-Bill“) investing services on the Public Platform are offered by Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information. When you enable T-Bill investing on the Public platform, you open a separate brokerage account with JSI (the “Treasury Account“). Get MarketBeat All Access Free for 30 DaysJoin thousands of other investors who make better investing decisions with our premium tools.

An indication of interest to purchase securities involves no obligation or commitment of any kind. Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here.

What Has Cathie Wood Been Trading?

An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. MedTech companies’ results are likely to reflect base business recovery on a year-over-year basis. Let’s see how EXAS, MDT and IART are poised ahead of their earnings releases. Exact Sciences possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Love it or hate it, tech investing is back on the menu in 2023. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time.

• In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.
• Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
• Style is an investment factor that has a meaningful impact on investment risk and returns.
• Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price.
• Exact Sciences has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Intraday data delayed at least 15 minutes or per exchange requirements. Exact Sciences issued an update on its FY 2023 earnings guidance on Tuesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.27 billion-$2.31 billion, compared to the consensus revenue estimate of $2.29 billion.

Market cap is the total market value of a publicly traded company’s outstanding shares. According to 12 analysts, the average rating for EXAS stock is “Strong Buy.” The 12-month stock price forecast is $75.08, which is an increase of 17.18% from the latest price. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price.

Access advanced stock screeners, portfolio monitoring tools, proprietary research reports, and more. Exact Sciences has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. According to analysts’ consensus price target of $73.31, Exact Sciences has a forecasted upside of 14.4% from its current price of $64.07. Exact Sciences stock was originally listed at a price of $15.00 in Feb 1, 2001.